Literature DB >> 11333877

Kinetic analysis of the effect of poliovirus receptor on viral uncoating: the receptor as a catalyst.

S K Tsang1, B M McDermott, V R Racaniello, J M Hogle.   

Abstract

We examined the role of soluble poliovirus receptor on the transition of native poliovirus (160S or N particle) to an infectious intermediate (135S or A particle). The viral receptor behaves as a classic transition state theory catalyst, facilitating the N-to-A conversion by lowering the activation energy for the process by 50 kcal/mol. In contrast to earlier studies which demonstrated that capsid-binding drugs inhibit thermally mediated N-to-A conversion through entropic stabilization alone, capsid-binding drugs are shown to inhibit receptor-mediated N-to-A conversion through a combination of enthalpic and entropic effects.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11333877      PMCID: PMC114901          DOI: 10.1128/JVI.75.11.4984-4989.2001

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  28 in total

1.  Cell-induced conformational change in poliovirus: externalization of the amino terminus of VP1 is responsible for liposome binding.

Authors:  C E Fricks; J M Hogle
Journal:  J Virol       Date:  1990-05       Impact factor: 5.103

2.  Implications for viral uncoating from the structure of bovine enterovirus.

Authors:  M Smyth; J Tate; E Hoey; C Lyons; S Martin; D Stuart
Journal:  Nat Struct Biol       Date:  1995-03

3.  WIN 51711-dependent mutants of poliovirus type 3: evidence that virions decay after release from cells unless drug is present.

Authors:  A G Mosser; R R Rueckert
Journal:  J Virol       Date:  1993-03       Impact factor: 5.103

4.  Characterization of poliovirus conformational alteration mediated by soluble cell receptors.

Authors:  A Gómez Yafal; G Kaplan; V R Racaniello; J M Hogle
Journal:  Virology       Date:  1993-11       Impact factor: 3.616

5.  Structure of a human rhinovirus complexed with its receptor molecule.

Authors:  N H Olson; P R Kolatkar; M A Oliveira; R H Cheng; J M Greve; A McClelland; T S Baker; M G Rossmann
Journal:  Proc Natl Acad Sci U S A       Date:  1993-01-15       Impact factor: 11.205

6.  Influence of different ionic and pH environments on structural alterations of poliovirus and their possible relation to virus uncoating.

Authors:  K Wetz; T Kucinski
Journal:  J Gen Virol       Date:  1991-10       Impact factor: 3.891

7.  The structure of coxsackievirus B3 at 3.5 A resolution.

Authors:  J K Muckelbauer; M Kremer; I Minor; G Diana; F J Dutko; J Groarke; D C Pevear; M G Rossmann
Journal:  Structure       Date:  1995-07-15       Impact factor: 5.006

8.  Structures of poliovirus complexes with anti-viral drugs: implications for viral stability and drug design.

Authors:  R A Grant; C N Hiremath; D J Filman; R Syed; K Andries; J M Hogle
Journal:  Curr Biol       Date:  1994-09-01       Impact factor: 10.834

9.  The structure of human rhinovirus 16.

Authors:  M A Oliveira; R Zhao; W M Lee; M J Kremer; I Minor; R R Rueckert; G D Diana; D C Pevear; F J Dutko; M A McKinlay
Journal:  Structure       Date:  1993-09-15       Impact factor: 5.006

10.  Poliovirus neutralization by antibodies to internal epitopes of VP4 and VP1 results from reversible exposure of these sequences at physiological temperature.

Authors:  Q Li; A G Yafal; Y M Lee; J Hogle; M Chow
Journal:  J Virol       Date:  1994-06       Impact factor: 5.103

View more
  35 in total

1.  Thermostability of reovirus disassembly intermediates (ISVPs) correlates with genetic, biochemical, and thermodynamic properties of major surface protein mu1.

Authors:  Jason K Middleton; Tonya F Severson; Kartik Chandran; Anne Lynn Gillian; John Yin; Max L Nibert
Journal:  J Virol       Date:  2002-02       Impact factor: 5.103

Review 2.  Poliovirus cell entry: common structural themes in viral cell entry pathways.

Authors:  James M Hogle
Journal:  Annu Rev Microbiol       Date:  2002-01-30       Impact factor: 15.500

3.  Parvovirus infection of cells by using variants of the feline transferrin receptor altering clathrin-mediated endocytosis, membrane domain localization, and capsid-binding domains.

Authors:  Karsten Hueffer; Laura M Palermo; Colin R Parrish
Journal:  J Virol       Date:  2004-06       Impact factor: 5.103

4.  Genogroup II noroviruses efficiently bind to heparan sulfate proteoglycan associated with the cellular membrane.

Authors:  Masaru Tamura; Katsuro Natori; Masahiko Kobayashi; Tatsuo Miyamura; Naokazu Takeda
Journal:  J Virol       Date:  2004-04       Impact factor: 5.103

5.  Adenovirus protein VI mediates membrane disruption following capsid disassembly.

Authors:  Christopher M Wiethoff; Harald Wodrich; Larry Gerace; Glen R Nemerow
Journal:  J Virol       Date:  2005-02       Impact factor: 5.103

6.  Dissociation of an antiviral compound from the internal pocket of human rhinovirus 14 capsid.

Authors:  Yumin Li; Zhigang Zhou; Carol Beth Post
Journal:  Proc Natl Acad Sci U S A       Date:  2005-05-17       Impact factor: 11.205

7.  Thermostabilizing mutations in reovirus outer-capsid protein mu1 selected by heat inactivation of infectious subvirion particles.

Authors:  Jason K Middleton; Melina A Agosto; Tonya F Severson; John Yin; Max L Nibert
Journal:  Virology       Date:  2007-01-17       Impact factor: 3.616

8.  Crystal structure of CD155 and electron microscopic studies of its complexes with polioviruses.

Authors:  Ping Zhang; Steffen Mueller; Marc C Morais; Carol M Bator; Valorie D Bowman; Susan Hafenstein; Eckard Wimmer; Michael G Rossmann
Journal:  Proc Natl Acad Sci U S A       Date:  2008-11-14       Impact factor: 11.205

9.  Interaction of parvovirus B19 with human erythrocytes alters virus structure and cell membrane integrity.

Authors:  Claudia Bönsch; Christoph Kempf; Carlos Ros
Journal:  J Virol       Date:  2008-09-24       Impact factor: 5.103

10.  Interactions of foot-and-mouth disease virus with soluble bovine alphaVbeta3 and alphaVbeta6 integrins.

Authors:  Hernando Duque; Michael LaRocco; William T Golde; Barry Baxt
Journal:  J Virol       Date:  2004-09       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.